COVID-19 Medication Paxlovid's Price Expected to Rise in 2024 As the US leaves the pandemic's emergency phase, the price of Paxlovid, a crucial COVID-19 drug, is expected to rise. by Quincy Jon
Health FDA Approves New Pfizer and Moderna COVID-19 Vaccines Targeting Omicron Variant XBB.1.5 by Inno Flores
Health FDA Approves Another COVID-19 Booster Vaccine for 65 Years and Older—When is it Available? by Isaiah Richard
Tech UK Watchdog Deems Pfizer CEO Albert Bourla's Statements on Kids' Covid Vaccines 'Misleading' by Trisha Kae Andrada
Tech Pfizer Pours in Almost $120 million for App that Detects Covid from Cough by Joaquin Victor Tacla
Health Pfizer-BioNTech Seeks Emergency Use of Covid Booster for Children Aged 5-11 by Joaquin Victor Tacla
Health Moderna Sues Pfizer, BioNTech for Use of mRNA Technology in COVID Vaccines—Pfizer Responds by Isaiah Richard
Health Pfizer to Bring COVID-19 Omicron Booster Shots this Fall—Is It Still a Need? by Isaiah Richard
Health Modified Pfizer Omicron-Based Vaccine Boosts Defense Against Variant? FDA To Discuss Tweaked COVID-19 Medicine by Griffin Davis
Health Pfizer Found Effective in Children Under 5, Experts to Make Recommendations This Week by Thea Felicity
Health Pfizer Issues a Recall for 3 Blood Pressure Meds Over Significant Risks Including Cancer, and MORE by Isaiah Richard
Health Pfizer Pushes for 4th COVID-19 Vaccine Dose: Is This for Life After the Pandemic? by Isaiah Richard
Health Pfizer 4th COVID-19 Vaccine Shot Data: Findings Show Booster's Efficiency Disappears After Four Months by Griffin Davis
Health Free COVID Antiviral Pills to Roll Out in the US | Here's Everything You Need to Know About 'Test to Treat' Program by Joseph Henry
Health COVID-19 Pill: Asks for More Payment, Threatens Access—Does it Mean it Will be More Expensive? by Isaiah Richard
Health Pfizer COVID Vaccine: FDA Approval for Use on Children Ages 6 Mos. to 4 Years Old Now Processing by Isaiah Richard
Health Omicron-Specific Pfizer Vaccine's Clinical Trials Begin To Test Efficiency and Safety by Griffin Davis
Health Pfizer COVID-19 Pill Paxlovid Gets FDA Authorization, But How Effective Is It? by Isaiah Richard
Health Pfizer, Moderna to ‘Update’ Vaccines to Work Against New Extremely Infectious Variants, WHO Warns by Isaiah Richard
Health Cheap Pfizer COVID-19 Pill? New Licensing Agreement to Allow Generic-Drug Makers to Produce the Medicine by Griffin Davis
Health Pfizer COVID-19 Booster Shots to Ask for FDA Approval for Adults—Is it Available for ‘Mix and Match’? by Isaiah Richard
Health Pfizer Says Its COVID-19 Pill Reduces Risk of Hospitalization and Death by 89% by Isabella James
Health COVID-19 Vaccine for Kids 5 to 11 Gets FDA Approval for EUA, May Begin in the Coming Weeks by Isaiah Richard
Health Edible Vaccine? Researchers Aim to Put mRNA Components from Pfizer, Moderna in Plants by Isaiah Richard
Health Pfizer COVID-19 Vaccine's Protection Weakens But Remains High After Six Months, Strengthens Call for Boosters by Isabella James
Health COVID-19 Vaccine for Children Ages 5 to 11 Years Old May Come Soon from Manufacturers, as Requested by the FDA—Is it Safe? by Isaiah Richard
Health COVID-19 Study Shows That Those Who Had Allergic Reactions to 1st Shot of mRNA Vaccines Can Get 2nd Dose by Isabella James
Health Johnson & Johnson's COVID-19 Vaccine Protects Less Against the Delta Variant; Experts, CDC Claim by Isaiah Richard
Health COVID-19 Vaccine for Kids 12 and Below are Coming, But Is It Safe? Everything You Need to Know by Isaiah Richard
Health COVID Boosters: WHO Slams Countries Ordering Boosters, More Serious Side Effects Warned by Isabella James
Health CDC, Fauci Thinks COVID-19 Boosters Are Not Essential As of The Moment, to Address its Need in Briefing by Isaiah Richard
Health Pfizer COVID-19 Booster to Get FDA Approval in August, Third Shot to Significantly Improve Immunity by Isaiah Richard
Health AstraZeneca COVID-19 Vaccine Protects More Against Delta, Kappa Variants Like Pfizer by Isaiah Richard
Health COVID-19 Vaccine: Study Shows Less Risks of Virus Infection After First Dose, Also for Coronavirus Variants by Isaiah Richard
Health mRNAs Are The Future of Vaccines After Pfizer, Moderna's Success Against COVID—HIV, Cancers Next-in-Line by Isaiah Richard
Health COVID-19 Vaccine Boosters Needed as Early as September with Pfizer. Moderna CEO Aims to Deliver By Year's End by Isaiah Richard
Health Mixing of COVID-19 Vacines Appears to be Safe But Could Lead to Adverse Reactions, Study Says by Joseph Henry